Last reviewed · How we verify
Imiquimod Topical Cream 3.75%
Imiquimod Topical Cream 3.75% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Imiquimod Topical Cream 3.75% |
|---|---|
| Sponsor | Sun Pharmaceutical Industries, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch (NA)
- Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma (NA)
- Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis (PHASE3)
- Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis. (PHASE1)
- Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis (PHASE4)
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses (NA)
- Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts (PHASE3)
- Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Imiquimod Topical Cream 3.75% CI brief — competitive landscape report
- Imiquimod Topical Cream 3.75% updates RSS · CI watch RSS
- Sun Pharmaceutical Industries, Inc. portfolio CI
Frequently asked questions about Imiquimod Topical Cream 3.75%
What is Imiquimod Topical Cream 3.75%?
Imiquimod Topical Cream 3.75% is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc..
Who makes Imiquimod Topical Cream 3.75%?
Imiquimod Topical Cream 3.75% is developed by Sun Pharmaceutical Industries, Inc. (see full Sun Pharmaceutical Industries, Inc. pipeline at /company/sun-pharmaceutical-industries-inc).
What development phase is Imiquimod Topical Cream 3.75% in?
Imiquimod Topical Cream 3.75% is in Phase 1.